CLVT
Clarivate Plc
CLVT trails on the overall score without a compensating advantage in the available component scores.
INTC
Intel Corporation
INTC has the edge over CLVT overall, supported by stronger fundamentals and stronger modeled upside.
CLVT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Weak |
CLVT's cash flow is currently healthy, but its revenue, profitability and balance sheet are under pressure.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
CLVT PE Valuation
CLVT has no meaningful PE right now: it lost money over the past year.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
CLVT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CLVT's earnings and revenue to decline, though with profitability improving.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
INTC has the edge over CLVT on the outlook, with more favorable earnings and revenue expectations.
CLVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.62 | — |
| Q3 2026 | -$0.61 | -$0.04 |
| Q2 2026 | -$0.52 | +$0.10 |
| Q1 2026 | -$0.21 | +$0.76 |
| Q4 2025 | -$0.30 | +$0.66 |
| Q3 2025 | -$0.57 | +$1.41 |
| Q2 2025 | -$0.62 | +$1.28 |
| Q1 2025 | -$0.97 | +$0.68 |
| Q4 2024 | -$0.96 | +$0.51 |
CLVT has the edge over INTC on earnings, with more consistent year-over-year improvement.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
CLVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $481.6M | -23% |
| Q2 2026 | $587.3M | -5.5% |
| Q1 2026 | $585.5M | -1.4% |
| Q4 2025 | $617M | -6.9% |
| Q3 2025 | $623.1M | +0.1% |
| Q2 2025 | $621.4M | -4.4% |
| Q1 2025 | $593.7M | -4.4% |
| Q4 2024 | $663M | -3% |
CLVT's revenue has slid since its 2022 peak: $482M last quarter, down 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | +1.3 points |
| Q2 2026 | -34% | -35 points |
| Q1 2026 | 5.2% | +8.7 points |
| Q4 2025 | 6.7% | +16 points |
| Q3 2025 | 7.1% | +3.6 points |
| Q2 2025 | 1.1% | +38 points |
| Q1 2025 | -3.5% | -4.3 points |
| Q4 2024 | -9.4% | +106 points |
CLVT's operating margin was 8.3% last quarter, up 1.3 points from the same quarter a year ago.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC has the edge over CLVT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over CLVT on profitability, with a higher operating margin.
CLVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $110.2M | -4.6% |
| Q2 2026 | $44M | -13% |
| Q1 2026 | $78.9M | -28% |
| Q4 2025 | $89.2M | +51% |
| Q3 2025 | $115.5M | -8.6% |
| Q2 2025 | $50.3M | -17% |
| Q1 2025 | $110.3M | -1.3% |
| Q4 2024 | $59.1M | -53% |
CLVT still generates free cash flow, though less than at its 2023 peak: $322M over the past year.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over CLVT on cash flow, with more consistent year-over-year improvement.
CLVT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.1x | High |
| Q2 2026 | 6.0x | High |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 4.9x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 6.1x | High |
| Q1 2025 | 9.7x | High |
| Q4 2024 | 9.4x | High |
CLVT's net debt is about 6.1 years of its operating earnings (EBITDA), up from 5.7 years a year ago.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC has the edge over CLVT on leverage, with a lower net debt burden relative to earnings.
CLVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.8 | Neutral |
| Stochastic | 66.9 | Neutral |
CLVT's weekly RSI is 54 (neutral) and its Stochastic is 67 (neutral).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CLVT PE vs Technology Sector
| Metric | CLVT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLVT has no meaningful PE right now: it lost money over the past year.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
CLVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.85 | 24% above |
| 20 week MA | $1.99 | 16% above |
| 50 week MA | $2.38 | 3.4% below |
| 100 week MA | $3.29 | 30% below |
| 200 week MA | $5.46 | 58% below |
CLVT has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 58% below its 200-week average.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
CLVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.0 | $30.1 | +77% |
| 2021 | $30.1 | $24.7 | -18% |
| 2022 | $24.7 | $8.16 | -67% |
| 2023 | $8.16 | $9.26 | +13% |
| 2024 | $9.26 | $5.12 | -45% |
| 2025 | $5.12 | $3.50 | -32% |
| 2026 YTD | $3.50 | $2.30 | -34% |
CLVT has finished lower in four of the last six years. It's down 34% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over CLVT on returns for 2026, with the stronger performance.